Home  >  News
Eppen_Research3_6neo_Aug26
you can get e-magazine links on WhatsApp. Click here
News
  UK MHRA authorises Eli Lilly’s orforglipron for weight management and type 2 diabetes,   August 12, 2026
  Merck expands biosafety testing laboratory in Singapore to strengthen services across Asia Pacific,   August 12, 2026
  Bristol Myers Squibb advances US manufacturing investment with new $2.3 billion campus in Houston, Texas,   August 12, 2026
  Boehringer Ingelheim acquires Swiss biotech company, Evax AG,   August 12, 2026
  Innate Pharma enters strategic partnership with Sobi to license lacutamab in T-cell lymphoma,   August 11, 2026
  ICC Arbitral Tribunal issues Quantum Award for AOP Health in BESREMi proceedings,   August 10, 2026
  US FDA grants fast track designation to BioInvent’s BI-1808 for the treatment of ovarian cancer,   August 10, 2026
  US FDA clears RiboX Therapeutics’ IND application for RXIM002, a circRNA-based in vivo CAR-T therapy for autoimmune cytopenias,   August 10, 2026
  US FDA completes pre-license inspection at CPC Scientific’s Hangzhou cGMP manufacturing facility for Hepcludex API,   August 07, 2026
  Takeda’s oral orexin receptor 2 agonist, Orzeyful receives US FDA approval to treat the underlying cause of narcolepsy type 1,   August 07, 2026
  US FDA accepts Merck’s sBLA for Enflonsia to update its RSV LRTD indication to include children under two years at increased risk for severe RSV for their second season,   August 07, 2026
  Reckitt receives US FDA approval for Mucinex 12HR Cold & Fever Multi-Symptom,   August 06, 2026
  UK’s Innovative Licensing and Access Pathway grants Innovation Passports to investigational products for cancer and dementia,   August 06, 2026
  CervoMed’s neflamapimod awarded Innovation Passport Designation under the UK ILAP for treatment of dementia with Lewy bodies,   August 05, 2026
  Pathos AI inks collaboration and co-exclusive licensing agreement with AstraZeneca to advance novel ERa PROTAC for ER+ breast cancer into the clinic,   August 05, 2026
  Innogen Pharma’s Efsubaglutide alfa manufacturing facility in Suzhou receives Brazilian ANVISA PIC/S GMP certification,   August 05, 2026
  European Commission approves Sanofi’s MenQuadfi for use in infants from age six weeks against invasive meningococcal disease,   August 05, 2026
  US FDA grants fast track designation to Aravax’s PVX108, a next-generation immunotherapy to treat peanut allergy,   August 04, 2026
  Eli Lilly's olomorasib receives US FDA's Breakthrough Therapy designation to treat previously treated KRAS G12C-mutant advanced pancreatic cancer,   August 04, 2026
  GSI Group Holdings expands platform with acquisition of Aven Tools,   August 04, 2026

  • Results Found: 22899
  • 1
    •  
  • 2
    •  
  • 3
    •  
  • 4
    •  
  • 5
    •  
  • Go to
  • Total Number of Pages: 1145
 Back
 
NPME-2026
cphi_korea2026
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram